ARTICLE | Finance
Regeneron Pharmaceuticals Inc.
February 28, 2000 8:00 AM UTC
Market value tracking: Regeneron Pharmaceuticals Inc. Regeneron (REGN) rose $15.75 (75 percent) to $36.625 on Wednesday as Merrill Lynch analyst Eric Hecht began coverage with an intermediate term "a...